Question 1

What specific benefits might INGN 201 offer compared to methotrexate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate clinical trial (NCT00041613). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my eligibility for this trial be determined?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate clinical trial (NCT00041613). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of INGN 201?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate clinical trial (NCT00041613). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate clinical trial (NCT00041613). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate clinical trial (NCT00041613). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate clinical trial (NCT00041613). Contact the study team or your healthcare provider for specific answers.

What this study is about